Navigation Links
Adynxx Completes Patient Enrollment in Phase 2 Clinical Study of Lead Therapeutic for Prevention of Pain, AYX1
Date:9/5/2013

SAN FRANCISCO, Sept. 5, 2013 /PRNewswire/ -- Adynxx, a clinical-stage pharmaceutical company developing a transformative, first-in-class platform of therapeutics to address pain at its molecular roots, announced today the completion of enrollment in a Phase 2 clinical study of its lead product candidate, AYX1, for reduction of acute post-surgical pain and prevention of the transition to persistent or chronic pain with a single administration at the time of surgery.  The U.S. Food and Drug Administration (FDA) granted Fast Track designation to AYX1 Injection for the prevention of chronic pain in July 2013.

The 102-subject, seven-center, randomized, placebo-controlled study is currently evaluating the safety and efficacy of a single intrathecal administration of AYX1 given prior to unilateral total knee arthroplasty (TKA) to reduce acute pain and to prevent the transition to persistent pain. The study is following subjects for 42 days, with a primary endpoint of pain with walking. Secondary and exploratory endpoints include pain at rest, pain with knee range of motion, rate and extent of functional recovery, opioid consumption and safety assessments. Further details of the study can be found at www.clinicaltrials.gov using the identifier NCT01731730.

"We believe AYX1 has the potential to revolutionize the treatment of post-surgical pain, and we are pleased to have efficiently and successfully completed enrollment in this Phase 2 study," said Donald Manning, M.D., Ph.D., chief medical officer of Adynxx. "With enrollment complete, we look forward to receiving and evaluating the study data in the next quarter and continuing to advance through development."

Dennis Podlesak, chairman of the Adynxx board of directors, added, "As evidenced by the recent Fast Track designation of AYX1, this treatment could potential
'/>"/>

SOURCE Adynxx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
2. Lead Therapeutic Candidate for Treatment of Pain from Adynxx, AYX1, Well-Tolerated in Phase 1 Clinical Study
3. Adynxx Completes Enrollment in Phase 1 Clinical Study of Lead Therapeutic for Treatment of Pain, AYX1
4. Otonomy Completes $45.9 Million Series C Equity Financing
5. BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan
6. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
7. OPKO Completes Acquisition Of PROLOR Biotech
8. Sleep Nation, Inc. Completes 43 Acquisitions
9. Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension
10. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
11. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)...  Hill-Rom Holdings, Inc. (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 8, ... invited to listen to the live discussion via the ... directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of ... of the live event and accessible at the links ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting ... prestigious R&D 100 Award for the new OSRAM ITOS ® ... LED-based white light module for microscopy, endoscopy and surgical head ... with significantly higher efficacy and lamp life. "We,re ... one of the most innovative new technologies of the past ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... Drug Administration (FDA) has granted priority review designation for ... Ivabradine is an oral drug that inhibits the ... sinoatrial node, the body,s cardiac pacemaker. 1 Ivabradine ... on myocardial contractility or ventricular repolarization. 1 Heart ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... President and Chief Executive Officer, will present at ... the Westin St. Francis Hotel in San Francisco, ... PT. About Omthera Pharmaceuticals, Inc.Founded ...
... Medical Technologies, Inc. today announced that Allina Hospitals ... company,s integrated electronic health record (EHR) practice management ... across Minnesota and western Wisconsin. ... ability to interface tightly with Allina,s Epic-based electronic ...
Cached Medicine Technology:Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 2Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 3
(Date:8/28/2014)... MarijuanaDoctors.com is enthralled to announce the addition ... Livermore, California. As always, MarijuanaDoctors.com prides itself on affiliating ... in accordance with that, we are excited to introduce ... , Initially finding his calling for healing and interest ... shaped by his mother’s severe arthritis to finally become ...
(Date:8/28/2014)... Texas (PRWEB) August 28, 2014 The need ... growth over the past few years. The new location - ... offer higher quality and larger office space than TLC had ... , “We are pleased about our new location because ... “While our suite will be double in size compared to ...
(Date:8/27/2014)... Villanova, PA (PRWEB) August 28, 2014 ... (published by iUniverse) takes readers on the thrilling adventures ... The book, published in 2012, is gearing up for ... 2014. , Split into two novellas , “Prescription: ... orthopedic surgeon who finds himself dodging assassination attempts and ...
(Date:8/27/2014)... Recently, BambooIndustry.com, an innovative company that provides many kinds of ... panels are now offered on its website. In addition, ... All people that place an order for its newly released ... percent off. , The company’s senior spokesman was excited ... our new and old customers can buy cheap bamboo panels ...
(Date:8/27/2014)... National Resident Matching Program International ... Medical Education in Europe (AMEE) Conference being held at ... – September 3, 2014. As an exhibitor, NRMPI ... community, share the benefits of its matching services, and ... in countries throughout the world. , “Exhibiting ...
Breaking Medicine News(10 mins):Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... 23 James. G. Schwade, M.D. announces the newly enhanced CyberKnife ... ( www.cyberknifemiami.com ). , The CyberKnife treatment for cancer ... cells with no invasive surgical incision. The length of the ... usually completed in 1- 5 treatments. , As the ...
... 20 percent get infected within one year of starting to ... News) -- As many as one in four U.S. teenage ... soon after their first sexual encounter, a new government report ... reminds us that we can,t ignore this," said study author ...
... is leading an initiative that could result in a paradigm ... Morehouse University School of Medicine and University of ... care physicians across Georgia to serve as "medical homes" for ... sends them to the hospital and seeking better prevention and ...
... , ... Instacare Corp. (OTC Bulletin Board: ISCR) announced today that its ... e-health technologies have been successfully engineered to seamlessly function on ... hand-held interactive medical software to the Apple iPhone, the Palm ...
... , NEW ORLEANS, Nov. 23 Thanksgiving weekend marks the 36th annual ... the sportsmanship and pride of two schools but it is so much ... in attendance. , For the crew of the new U.S. Coast Guard ... before they work to test and launch a brand new ship to ...
... ... and Automate Billing, Claims, Enrollment and Eligibility, , ... (PRWEB) November 23, 2009 -- BridgeGate ... the launch of new products within its healthcare integration suite, designed to help ...
Cached Medicine News:Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:Nothing Is Like Being There 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: